PTGDS Human

Prostaglandin D2 Synthase Human Recombinant
Cat. No.
BT24615
Source
Escherichia Coli.
Synonyms

Prostaglandin-H2 D-isomerase, Beta-trace protein, Cerebrin-28, Glutathione-independent PGD synthase, Lipocalin-type prostaglandin-D synthase, Prostaglandin-D2 synthase, PGD2 synthase, PGDS, PGDS2, PTGDS, PDS, PGD2, LPGDS, L-PGDS.

Appearance
Sterile filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

PTGDS produced in E.Coli is a single, non-glycosylated polypeptide chain containing 189 amino acids (23-190 a.a.) and having a molecular mass of 20.9kDa.
PTGDS is fused to a 21 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction

Prostaglandin-H2 D-isomerase (PTGDS) is a glutathione-independent enzyme responsible for converting prostaglandin H2 into prostaglandin D2. It may play a crucial role in the development and upkeep of the central nervous system and the male reproductive system. As the most abundant protein found in cerebrospinal fluid, PTGDS is believed to act as a chaperone for beta-amyloid, potentially contributing to the formation of amyloid plaques seen in Alzheimer's disease.

Description

The PTGDS produced in E. coli is a single polypeptide chain that lacks glycosylation. It comprises 189 amino acids (specifically, amino acids 23 to 190) and has a molecular weight of 20.9 kDa. The protein includes a 21 amino acid His-tag fused to its N-terminus and is purified using proprietary chromatographic methods.

Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
This solution contains PTGDS at a concentration of 1 mg/ml. It is prepared with a 20mM Tris-HCl buffer at pH 8.0, supplemented with 1mM DTT, 30% glycerol, 1mM EDTA, and 0.1M NaCl.
Stability
For short-term storage (up to 2-4 weeks), the product can be kept at 4°C. For extended storage, it is recommended to freeze the product at -20°C. The addition of a carrier protein (either 0.1% HSA or BSA) is advised for long-term storage. To maintain product integrity, minimize repeated freeze-thaw cycles.
Purity
Analysis by SDS-PAGE indicates a purity exceeding 90.0%.
Synonyms

Prostaglandin-H2 D-isomerase, Beta-trace protein, Cerebrin-28, Glutathione-independent PGD synthase, Lipocalin-type prostaglandin-D synthase, Prostaglandin-D2 synthase, PGD2 synthase, PGDS, PGDS2, PTGDS, PDS, PGD2, LPGDS, L-PGDS.

Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MAPEAQVSVQ PNFQQDKFLG RWFSAGLASN SSWLREKKAA LSMCKSVVAP ATDGGLNLTS TFLRKNQCET RTMLLQPAGS LGSYSYRSPH WGSTYSVSVV ETDYDQYALL YSQGSKGPGE DFRMATLYSR TQTPRAELKE KFTAFCKAQG FTEDTIVFLP QTDKCMTEQ.

Product Science Overview

Introduction

Prostaglandin D2 Synthase (PGDS) is an enzyme that plays a crucial role in the conversion of prostaglandin H2 (PGH2) to prostaglandin D2 (PGD2). This enzyme is significant in various physiological processes, including neuromodulation, smooth muscle contraction/relaxation, and inhibition of platelet aggregation .

Biochemical Characteristics

PGDS is a glutathione-independent enzyme, meaning it does not require glutathione to function. It catalyzes the isomerization of PGH2, a common precursor of prostanoids, to produce PGD2 . PGD2 is involved in several central nervous system (CNS) functions, such as sedation, non-rapid eye movement (NREM) sleep, and may have an anti-apoptotic role in oligodendrocytes .

Gene and Protein Structure

The gene encoding PGDS is known as PTGDS. It is a protein-coding gene associated with various pathways, including fatty acid metabolism and mammalian disorders of sexual development . The protein itself is a member of the lipocalin family, which is composed of secretory proteins that bind and transport lipophilic small substances .

Physiological and Pathological Roles

PGD2 functions as a neuromodulator and a trophic factor in the CNS. It is also involved in smooth muscle contraction/relaxation and is a potent inhibitor of platelet aggregation . Additionally, PGD2 has been found to play roles in sleep regulation, pain modulation, and food intake . It is secreted into cerebrospinal fluid (CSF), seminal plasma, and plasma, acting as an extracellular carrier of various substances .

Clinical Significance

PGDS has been implicated in several diseases, including bronchus cancer and cerebrospinal fluid leak . Its role in the CNS and other physiological processes makes it a potential target for therapeutic interventions. Studies with transgenic mice overexpressing this gene suggest that it may also be involved in the regulation of non-rapid eye movement sleep .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.